{"id":72266,"date":"2026-08-11T12:46:49","date_gmt":"2026-08-11T04:46:49","guid":{"rendered":"https:\/\/flcube.com\/?p=72266"},"modified":"2026-08-11T12:46:51","modified_gmt":"2026-08-11T04:46:51","slug":"xbiome-and-biomap-sign-strategic-cooperation-agreement-to-advance-ai-powered-microbiome-drug-and-probiotic-product-rd","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=72266","title":{"rendered":"Xbiome and BioMap Sign Strategic Cooperation Agreement to Advance AI\u2011Powered Microbiome Drug and Probiotic Product R&amp;D"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Xbiome<\/strong>, a China\u2011based <strong>AI\u2011driven microbiome drug development company<\/strong>, and <strong>BioMap<\/strong> officially signed a <strong>strategic cooperation agreement<\/strong>, the companies announced. The partnership will focus on <strong>AI\u2011empowered innovation in microbiome drug and probiotic product R&amp;D<\/strong>, integrating their core strengths in <strong>foundation models for life sciences<\/strong> and <strong>microbiome technologies<\/strong> to accelerate micro\u2011ecological R&amp;D efficiency and unlock new growth opportunities in the <strong>AI + microbiome sector<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-deal-overview\" class=\"wp-block-heading\">Deal Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Parties<\/strong><\/td><td>Xbiome (China) \u00d7 BioMap<\/td><\/tr><tr><td><strong>Deal Type<\/strong><\/td><td>Strategic cooperation agreement<\/td><\/tr><tr><td><strong>Signing Date<\/strong><\/td><td>15 Jul 2026<\/td><\/tr><tr><td><strong>Focus<\/strong><\/td><td>AI\u2011empowered innovation in microbiome drug and probiotic product R&amp;D<\/td><\/tr><tr><td><strong>Core Strengths Combined<\/strong><\/td><td>BioMap&#8217;s foundation models for life sciences + Xbiome&#8217;s microbiome technologies<\/td><\/tr><tr><td><strong>Strategic Goal<\/strong><\/td><td>Accelerate micro\u2011ecological R&amp;D efficiency; unlock growth in the AI + microbiome sector<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-four-pillars-of-collaboration\" class=\"wp-block-heading\">Four Pillars of Collaboration<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The two companies will engage in deep collaboration across four major areas:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Pillar<\/th><th>Scope<\/th><\/tr><\/thead><tbody><tr><td><strong>1. Joint Technical Platform Development<\/strong><\/td><td>Co\u2011building integrated R&amp;D platforms<\/td><\/tr><tr><td><strong>2. Joint Model Building<\/strong><\/td><td>Co\u2011developing AI microbiome models<\/td><\/tr><tr><td><strong>3. Joint Market Expansion<\/strong><\/td><td>Co\u2011expanding across commercial verticals<\/td><\/tr><tr><td><strong>4. Ecosystem Talent Synergy<\/strong><\/td><td>Aligning talent and ecosystem resources<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-technology-integration-foundation-models-meet-microbiome-platforms\" class=\"wp-block-heading\">Technology Integration \u2013 Foundation Models Meet Microbiome Platforms<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Addressing <strong>Xbiome&#8217;s<\/strong> R&amp;D needs in microbiome therapeutics and probiotics, the partnership will foster deep synergy between:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>BioMap&#8217;s assets:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>xTrimo<\/strong> \u2014 foundation model for life sciences<\/li>\n\n\n\n<li><strong>BioMap OS<\/strong> \u2014 dry\u2011wet closed\u2011loop discovery system<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Xbiome&#8217;s three core platforms:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Bioinformatics platform<\/li>\n\n\n\n<li>Microbiology platform<\/li>\n\n\n\n<li>Molecular biology platform<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">This cross\u2011domain technological integration is designed to combine AI\u2011driven computational discovery with experimental validation loops, improving R&amp;D efficiency across microbiome drug and probiotic development.<\/p>\n\n\n\n<h2 id=\"h-market-expansion-three-core-areas\" class=\"wp-block-heading\">Market Expansion \u2013 Three Core Areas<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Both parties will integrate technical, channel, supply chain, and ecosystem partner resources to jointly expand across three core areas:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Sector<\/th><th>Offering<\/th><\/tr><\/thead><tbody><tr><td><strong>Food &amp; Dairy Industry<\/strong><\/td><td>Leveraging jointly built <strong>AI microbiome models<\/strong> and <strong>automated screening capabilities<\/strong> to provide functional food and dairy enterprises with integrated solutions covering <strong>strain screening, functional validation, and process optimization<\/strong><\/td><\/tr><tr><td><strong>Pharmaceutical &amp; Healthcare Sector<\/strong><\/td><td>Relying on combined advantages in <strong>microbiomics and AI technology<\/strong> to offer pharmaceutical companies and medical institutions automated <strong>dry\u2011wet integrated AI microbiome drug development solutions<\/strong>, spanning from early\u2011stage R&amp;D to in vitro efficacy validation<\/td><\/tr><tr><td><strong>Scientific Research Services<\/strong><\/td><td>Co\u2011building an <strong>AI + scientific computing service system<\/strong> to support joint applications for major research projects at various levels and co\u2011publishing high\u2011impact academic achievements by scientists from both organizations<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-strategic-rationale-amp-market-impact\" class=\"wp-block-heading\">Strategic Rationale &amp; Market Impact<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>AI \u00d7 Microbiome Convergence:<\/strong> The deal positions <strong>Xbiome<\/strong> and <strong>BioMap<\/strong> at the intersection of two fast\u2011moving fields \u2014 foundation models for life sciences and microbiome therapeutics \u2014 a combination still rare in the global biotech landscape.<\/li>\n\n\n\n<li><strong>Platform\u2011to\u2011Market Breadth:<\/strong> Unlike single\u2011asset collaborations, this agreement spans technology platforms, AI model co\u2011development, commercialization across food, pharma and research services, and talent \u2014 creating multiple potential revenue vectors.<\/li>\n\n\n\n<li><strong>Therapeutics + Consumer Dual Track:<\/strong> The partnership covers both <strong>microbiome drug development<\/strong> and <strong>probiotic products<\/strong>, balancing long\u2011cycle pharmaceutical upside with nearer\u2011term commercial opportunities in the food and dairy industry.<\/li>\n\n\n\n<li><strong>Ecosystem Play:<\/strong> Joint research applications, co\u2011published academic output and an AI + scientific computing service system reinforce the partnership&#8217;s positioning within China&#8217;s broader life\u2011sciences innovation ecosystem.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding the partnership&#8217;s platform development, model building, and market expansion plans. Actual results may differ due to risks including technology development outcomes, regulatory pathways, and market adoption dynamics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Xbiome, a China\u2011based AI\u2011driven microbiome drug development company, and BioMap officially signed a strategic cooperation&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10],"tags":[99,3880,2966],"class_list":["post-72266","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-ai","tag-biomap","tag-xbiome"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Xbiome and BioMap Sign Strategic Cooperation Agreement to Advance AI\u2011Powered Microbiome Drug and Probiotic Product R&amp;D - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Xbiome, a China\u2011based AI\u2011driven microbiome drug development company, and BioMap officially signed a strategic cooperation agreement, the companies announced. The partnership will focus on AI\u2011empowered innovation in microbiome drug and probiotic product R&amp;D, integrating their core strengths in foundation models for life sciences and microbiome technologies to accelerate micro\u2011ecological R&amp;D efficiency and unlock new growth opportunities in the AI + microbiome sector.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=72266\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Xbiome and BioMap Sign Strategic Cooperation Agreement to Advance AI\u2011Powered Microbiome Drug and Probiotic Product R&amp;D\" \/>\n<meta property=\"og:description\" content=\"Xbiome, a China\u2011based AI\u2011driven microbiome drug development company, and BioMap officially signed a strategic cooperation agreement, the companies announced. The partnership will focus on AI\u2011empowered innovation in microbiome drug and probiotic product R&amp;D, integrating their core strengths in foundation models for life sciences and microbiome technologies to accelerate micro\u2011ecological R&amp;D efficiency and unlock new growth opportunities in the AI + microbiome sector.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=72266\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-11T04:46:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-11T04:46:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72266#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72266\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Xbiome and BioMap Sign Strategic Cooperation Agreement to Advance AI\u2011Powered Microbiome Drug and Probiotic Product R&amp;D\",\"datePublished\":\"2026-08-11T04:46:49+00:00\",\"dateModified\":\"2026-08-11T04:46:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72266\"},\"wordCount\":587,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"AI\",\"BioMap\",\"Xbiome\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=72266#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72266\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=72266\",\"name\":\"Xbiome and BioMap Sign Strategic Cooperation Agreement to Advance AI\u2011Powered Microbiome Drug and Probiotic Product R&amp;D - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-08-11T04:46:49+00:00\",\"dateModified\":\"2026-08-11T04:46:51+00:00\",\"description\":\"Xbiome, a China\u2011based AI\u2011driven microbiome drug development company, and BioMap officially signed a strategic cooperation agreement, the companies announced. The partnership will focus on AI\u2011empowered innovation in microbiome drug and probiotic product R&D, integrating their core strengths in foundation models for life sciences and microbiome technologies to accelerate micro\u2011ecological R&D efficiency and unlock new growth opportunities in the AI + microbiome sector.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72266#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=72266\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72266#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Xbiome and BioMap Sign Strategic Cooperation Agreement to Advance AI\u2011Powered Microbiome Drug and Probiotic Product R&amp;D\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Xbiome and BioMap Sign Strategic Cooperation Agreement to Advance AI\u2011Powered Microbiome Drug and Probiotic Product R&amp;D - Insight, China&#039;s Pharmaceutical Industry","description":"Xbiome, a China\u2011based AI\u2011driven microbiome drug development company, and BioMap officially signed a strategic cooperation agreement, the companies announced. The partnership will focus on AI\u2011empowered innovation in microbiome drug and probiotic product R&D, integrating their core strengths in foundation models for life sciences and microbiome technologies to accelerate micro\u2011ecological R&D efficiency and unlock new growth opportunities in the AI + microbiome sector.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=72266","og_locale":"en_US","og_type":"article","og_title":"Xbiome and BioMap Sign Strategic Cooperation Agreement to Advance AI\u2011Powered Microbiome Drug and Probiotic Product R&amp;D","og_description":"Xbiome, a China\u2011based AI\u2011driven microbiome drug development company, and BioMap officially signed a strategic cooperation agreement, the companies announced. The partnership will focus on AI\u2011empowered innovation in microbiome drug and probiotic product R&D, integrating their core strengths in foundation models for life sciences and microbiome technologies to accelerate micro\u2011ecological R&D efficiency and unlock new growth opportunities in the AI + microbiome sector.","og_url":"https:\/\/flcube.com\/?p=72266","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-08-11T04:46:49+00:00","article_modified_time":"2026-08-11T04:46:51+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=72266#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=72266"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Xbiome and BioMap Sign Strategic Cooperation Agreement to Advance AI\u2011Powered Microbiome Drug and Probiotic Product R&amp;D","datePublished":"2026-08-11T04:46:49+00:00","dateModified":"2026-08-11T04:46:51+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=72266"},"wordCount":587,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["AI","BioMap","Xbiome"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=72266#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=72266","url":"https:\/\/flcube.com\/?p=72266","name":"Xbiome and BioMap Sign Strategic Cooperation Agreement to Advance AI\u2011Powered Microbiome Drug and Probiotic Product R&amp;D - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-08-11T04:46:49+00:00","dateModified":"2026-08-11T04:46:51+00:00","description":"Xbiome, a China\u2011based AI\u2011driven microbiome drug development company, and BioMap officially signed a strategic cooperation agreement, the companies announced. The partnership will focus on AI\u2011empowered innovation in microbiome drug and probiotic product R&D, integrating their core strengths in foundation models for life sciences and microbiome technologies to accelerate micro\u2011ecological R&D efficiency and unlock new growth opportunities in the AI + microbiome sector.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=72266#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=72266"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=72266#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Xbiome and BioMap Sign Strategic Cooperation Agreement to Advance AI\u2011Powered Microbiome Drug and Probiotic Product R&amp;D"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72266","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=72266"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72266\/revisions"}],"predecessor-version":[{"id":72267,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72266\/revisions\/72267"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=72266"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=72266"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=72266"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}